Pathology of acromegaly

Neuroendocrinology

Volumn 83, Issue 3-4, 2006, Pages 161-165

  Horvath, Eva ^a   Kovacs, Kalman ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acromegaly; Growth hormone; Pituitary neoplasm

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE MESILATE; DOPAMINE RECEPTOR STIMULATING AGENT; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; PEGVISOMANT; PROLACTIN; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; BRONCHUS CARCINOID; CONFERENCE PAPER; ELECTRON MICROSCOPY; GROWTH HORMONE RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; PATHOLOGY; PRIORITY JOURNAL;

ACROMEGALY; ADENOMA; CARCINOMA; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 33750062886     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095524     Document Type: Conference Paper

References (22)

1. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV: The World Health Organization classification of adenohypophysial neoplasms: a five-tier scheme. Cancer 1996;78:502-510.
2. Kovacs K, Horvath E: Tumors of the pituitary gland; in Hartmann WH, Sobin LH (eds): Atlas of Tumor Pathology, 2nd series, fascicle 21. Washington, Armed Forces Institute of Pathology, 1986.
3. Kovacs K, Horvath E: Pathology of growth hormone producing tumors of the human pituitary. Semin Diagn Pathol 1986;3:18-33.
4. Horvath E, Scheithauer BW, Kovacs K: Morphological aspects of growth hormone producing pituitary adenomas with emphasis on novel concepts; in Lüdecke DK, Tolis G (eds): Growth Hormone, Growth Factors and Acromegaly. New York, Raven Press, 1987, pp 107-114.
5. Horvath E, Kovacs K: The adenohypophysis; in Kovacs K, Asa SL (eds): Functional Endocrine Pathology, ed 2. Malden, Blackwell, 1998, pp 247-281.
6. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV: Hypothalamus and pituitary; in Graham DI, Lantos PL (eds): Greenfield's Neuropathology, ed 7. London, Arnold, 2002, pp 983-1062.
7. Scheithauer BW, Kovacs K, Horvath E, Roncaroli F, Ezzat S, Asa SL, Nosé V, Watson RE Jr, Lindell EP: Pituitary carcinoma; in DeLellis RA, Lloyd RV, Heitz PN, Eng C (eds): World Health Organization Classification of Tumors. Pathology and Genetics, Tumors of Endocrine Organs. Lyon, IARC Press, 2004, pp 36-47.
8. Thorner MO, Perryman RL, Cronin MJ, Draznin MB, Johanson AJ, Rogol AD, Jane JA, Rudolf LE, Horvath E, Kovacs K, Vale W: Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone releasing factor. Trans Assoc Am Physicians 1982;95:177-178.
9. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 1999;402:656-660.
10. Corbetta S, Peracchi M, Cappiello V, Lania E, Vago L, Beck-Peccoz P, Spada A: Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab 2003;88:3117-3120.
11. Thorner MO, Martin WH, Rogol AD, Morris JL, Perryman RL, Conway BP, Howards SS, Wolfman HG, MacLeod RM: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 1980;51:438-445.
12. Tindall GT, Kovacs K, Horvath E, Thorner MO: Human prolactin producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab 1982;55:1178-1183.
13. Jaffe CA, Barkan AL: Treatment of acromegaly with dopamine agonist. Endocrinol Metab Clin North Am 1992;21:713-735.
14. Harris AG, Prestele H, Herold K, Boerlin V: Long term efficacy of Sandostatin (SMS 201-995, Octreotide) in 178 acromegalic patients. Results from the International Multicentre Acromegaly Study Group; in Lamberts SWJ (ed): Sandostatin in the Treatment of Acromegaly. Berlin, Springer, 1988, pp 117-125.
15. Freda PU: Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2002;87:3013-3018.
16. Vance ML: Medical treatment of functional pituitary tumors. Neurosurg Clin North Am 2003;14:81-89.
17. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ: Growth hormone receptor antagonists: discovery, development and use in patients with acromegaly. Endocr Rev 2002;23:623-646.
18. Parkinson C, Trainer DJ: The place of pegvisomant in the management of acromegaly. Endocrinologist 2003;13:408-416.
19. Paisley AN, Drake WH: Treatment of pituitary tumors. Pegvisomant. Endocrine 2005;28:111-114.
20. Newlands ES, Stevens MFG, Wedge SR, Wheelhouse RT, Brock C: Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997;23:35-61.
21. Fadul CE, Kominsky AL, Meyer LP, Kingman LS, Kinlaw WB, Rhodes CH, Eskey CJ, Pepin SE, Simmons NE: Pituitary carcinomas respond to Temozolomide. Neurooncology 2004;6:374.
22. Zhu Y, Shahinian H, Hakimian B, Bonert V, Lim S, Heaney A: Temodar: novel treatment for pituitary carcinoma (abstract). US Endocr Soc 2004;43:138.